» Articles » PMID: 27048230

Kidney Retransplantation in Children Following Rejection and Recurrent Disease

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 2016 Apr 7
PMID 27048230
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Retransplantation accounts for approximately 15 % of the annual transplants performed in the USA, and in the recent International Collaborative Transplant Study report on pediatric patients 15.2 % of the 9209 patients included in the report were retransplant recipients. Although the significant advances in clinical management and newer immunosuppressive agents have had a significant impact on improving short-term allograft function, it is apparent that long-term allograft function remains suboptimal. Therefore, it is likely that the majority of pediatric renal allograft recipients will require one or more retransplants during their lifetime. Unfortunately, a second or subsequent graft in pediatric recipients has inferior long-term graft survival rates compared to initial grafts, with decreasing rates with each subsequent graft. Multiple issues influence the outcome of retransplantation, with the most significant being the cause of the prior transplant failure. Non-adherence-associated graft loss poses unresolved ethical issues that may impact access to retransplantation. Graft nephrectomy prior to retransplantation may benefit selected patients, but the impact of an in situ failed graft on the development of panel-reactive antibodies remains to be definitively determined. It is important that these and other factors discussed in this review be taken into consideration during the counseling of families on the optimal approach for their child who requires a retransplant.

Citing Articles

Second kidney transplant during childhood: clinical aspects, outcomes, and risk factors for graft survival.

de Santis Feltran L, Hamamoto F, Genzani C, Fonseca M, de Carvalho M, Koch-Nogueira P Pediatr Nephrol. 2025; .

PMID: 39954072 DOI: 10.1007/s00467-025-06685-6.


Biomarker for recurrent immunoglobulin A nephropathy in kidney allografts: promising but still a long way to go.

Chung B Kidney Res Clin Pract. 2021; 40(2):180-182.

PMID: 34162047 PMC: 8237127. DOI: 10.23876/j.krcp.21.106.


Organ Transplant Recipients' Experiences of Physical Activity: Health, Self-Care, and Transliminality.

Wiltshire G, Clarke N, Phoenix C, Bescoby C Qual Health Res. 2020; 31(2):385-398.

PMID: 33124516 PMC: 7750649. DOI: 10.1177/1049732320967915.

References
1.
Harambat J, van Stralen K, Schaefer F, Grenda R, Jankauskiene A, Kostic M . Disparities in policies, practices and rates of pediatric kidney transplantation in Europe. Am J Transplant. 2013; 13(8):2066-74. DOI: 10.1111/ajt.12288. View

2.
Van Arendonk K, Garonzik Wang J, Deshpande N, James N, Smith J, Montgomery R . Practice patterns and outcomes in retransplantation among pediatric kidney transplant recipients. Transplantation. 2013; 95(11):1360-8. PMC: 3674132. DOI: 10.1097/TP.0b013e31828c6d64. View

3.
Canaud G, Bienaime F, Tabarin F, Bataillon G, Seilhean D, Noel L . Inhibition of the mTORC pathway in the antiphospholipid syndrome. N Engl J Med. 2014; 371(4):303-12. DOI: 10.1056/NEJMoa1312890. View

4.
Hirsch H, Randhawa P . BK polyomavirus in solid organ transplantation. Am J Transplant. 2013; 13 Suppl 4:179-88. DOI: 10.1111/ajt.12110. View

5.
McCaughan J, ORourke D, Courtney A . Recurrent dense deposit disease after renal transplantation: an emerging role for complementary therapies. Am J Transplant. 2012; 12(4):1046-51. DOI: 10.1111/j.1600-6143.2011.03923.x. View